A Phase I Study With SJG-136 (NSC #694501) in Patients With an Advanced Solid Tumor
Phase of Trial: Phase I
Latest Information Update: 10 Dec 2013
At a glance
- Drugs SG 2000 (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 17 Jul 2007 Status changed from suspended to completed.
- 07 Sep 2005 New trial record.